
Your cart is empty.
Start browsingGLP-1 and GIP receptor agonists for metabolic research.
7 products
The metabolic category groups compounds used in laboratory research on energy balance, glucose regulation and lipid metabolism. It includes incretin receptor agonists such as tirzepatide, a dual GIP and GLP-1 receptor agonist, and retatrutide, which also acts at the glucagon receptor. Alongside them are tesamorelin, a growth hormone–releasing hormone analogue; AOD-9604, a modified fragment of human growth hormone (residues 176–191); and 5-Amino-1MQ, a small-molecule NNMT inhibitor studied in cell and animal models.
Most compounds are supplied as lyophilised powder in sealed vials. Certificates from named outside laboratories are published unaltered on each product page, and a product still waiting for its Certificate is marked as such. Tirzepatide and retatrutide come in two vial sizes.
Shipped worldwide from Asia with tracking in 9–14 days. For laboratory research only; not for human consumption.